Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Beleave Inc BLEVF

Beleave Inc is a vertically integrated Canadian cannabis company. It operates streamlined facilities throughout Canada to cultivate high quality cannabis flower, oil and extracts with funded capacity more than 150,000 kilograms per year. Fully licensed to cultivate and sell medical and recreational cannabis, it is leading the way through research partnerships with universities to bridge the gap between science and tradition and to develop pharma-grade extracts and derivatives. The company is currently developing new product lines as the recreational market is expected to allow for food and beverage-based cannabis products.


GREY:BLEVF - Post by User

Bullboard Posts
Post by ArchimedesBon Nov 30, 2016 5:47pm
134 Views
Post# 25536783

Canada May Face Marijuana Shortage When It's Legalized

Canada May Face Marijuana Shortage When It's LegalizedCanada May Face Marijuana Shortage When It's Legalized: Canaccord

As a law-abiding news organization, we can't advise you to stock up on illegal weed before it goes legal.

But.

“We believe the rigorous process of becoming a licensed producer of cannabis in Canada imposes significant barriers to entry,” analysts Matt Bottomley and Neil Maruoka wrote in a research note this week.

“To date, Health Canada has approved 2 per cent of applications from growers seeking approval to supply the medical market."

Lack of production “will result in a shortfall of supply in the near term,” the analysts said, but that would help give the bud a “floor” price of $8 per gram. That’s similar in scale to what marijuana sells for on the black market today.

Bullboard Posts